Publications (102) María Ángeles Serrano García publications

2024

  1. Impact of genetic variants in the solute carrier (SLC) genes encoding drug uptake transporters on the response to anticancer chemotherapy

    CANCER DRUG RESISTANCE, Vol. 7

2022

  1. La Sociedad Española de Bioquímica y Biología Molecular: objetivos y desafíos

    Encuentros multidisciplinares, Vol. 24, Núm. 71

  2. Los beneficios de obtener sellos internacionales de calidad para enseñanzas universitarias argentinas, chilenas, ecuatorianas, españolas y mexicanas

    Revista Iberoamericana de Educación, Vol. 88, Núm. 1, pp. 49-66

2021

  1. Auditorías virtuales en el Programa de Sellos Internacionales de Calidad (SIC) de ANECA en tiempos de pandemia

    RIED: revista iberoamericana de educación a distancia, Vol. 24, Núm. 2, pp. 245-261

  2. Cuatro universidades españolas participarán en el proyecto piloto (2021-2022) del sello de la Federación Mundial de Educación Médica (WFME) gestionado por la Agencia Nacional de Evaluación de la Calidad y Acreditación (ANECA)

    FEM. Revista de la Fundación Educación Médica, Vol. 24, Núm. 3, pp. 109-111

2020

  1. Relationship between changes in the exon-recognition machinery and SLC22A1 alternative splicing in hepatocellular carcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1866, Núm. 5

  2. Role of genetic variations in the hepatic handling of drugs

    International Journal of Molecular Sciences, Vol. 21, Núm. 8

2019

  1. Epigenetic events involved in organic cation transporter 1-dependent impaired response of hepatocellular carcinoma to sorafenib

    British Journal of Pharmacology, Vol. 176, Núm. 6, pp. 787-800

2018

  1. Chemoprotective Role of Vitamin C in Liver Diseases

    The Liver: Oxidative Stress and Dietary Antioxidants (Elsevier), pp. 139-153

  2. Chemoresistance and chemosensitization in cholangiocarcinoma

    Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1864, Núm. 4, pp. 1444-1453

  3. Genetic heterogeneity of SLC22 family of transporters in drug disposition

    Journal of Personalized Medicine, Vol. 8, Núm. 2

  4. Molecular bases of the poor response of liver cancer to chemotherapy

    Clinics and Research in Hepatology and Gastroenterology

2017

  1. Molecular bases of chemoresistance in cholangiocarcinoma

    Current Drug Targets, Vol. 18, Núm. 8, pp. 889-900

2016

  1. Protective role of biliverdin against bile acid-induced oxidative stress in liver cells

    Free Radical Biology and Medicine, Vol. 97, pp. 466-477

2014

  1. The role of reduced intracellular concentrations of active drugs in the lack of response to anticancer chemotherapy

    Acta Pharmacologica Sinica, Vol. 35, Núm. 1, pp. 1-10

2013

  1. Genetic Variants Involved in Intracellular Mechanisms of Chemoresistance to Anticancer Drugs Due to Changes in the Effect on Their Molecular Targets

    eLS

  2. Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 14, pp. 4432-4441

2012

  1. Cisplatin-induced chemoresistance in colon cancer cells involves FXR-dependent and FXR-independent up-regulation of ABC proteins

    Molecular Pharmaceutics, Vol. 9, Núm. 9, pp. 2565-2576

  2. No correlation between the expression of FXR and genes involved in multidrug resistance phenotype of primary liver tumors

    Molecular Pharmaceutics, Vol. 9, Núm. 6, pp. 1693-1704

  3. Up-regulation of FXR isoforms is not required for stimulation of the expression of genes involved in the lack of response of colon cancer to chemotherapy

    Pharmacological Research, Vol. 66, Núm. 5, pp. 419-427